rosmarinate acid

CAS No. 537-15-5

rosmarinate acid( (R)-rosmarinic acid | Rosemary acid | rosmarinic acid )

Catalog No. M29445 CAS No. 537-15-5

Rosmarinate acid inhibits MAO-A, MAO-B and COMT enzymes with IC50s of 50.1, 184.6 and 26.7 μM, respectively

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 65 Get Quote
5MG 48 Get Quote
10MG 71 Get Quote
25MG 122 Get Quote
50MG 179 Get Quote
100MG 267 Get Quote
200MG 401 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    rosmarinate acid
  • Note
    Research use only, not for human use.
  • Brief Description
    Rosmarinate acid inhibits MAO-A, MAO-B and COMT enzymes with IC50s of 50.1, 184.6 and 26.7 μM, respectively
  • Description
    Rosmarinate acid inhibits MAO-A, MAO-B and COMT enzymes with IC50s of 50.1, 184.6 and 26.7 μM, respectively
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    (R)-rosmarinic acid | Rosemary acid | rosmarinic acid
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    MAO
  • Recptor
    MAO
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    537-15-5
  • Formula Weight
    360.318
  • Molecular Formula
    C18H16O8
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    [H][C@](Cc1ccc(O)c(O)c1)(OC(=O)\C=C\c1ccc(O)c(O)c1)C(O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • MAO-B-IN-8

    MAO-B-IN-8 is a highly potent and reversible inhibitor of monoamine oxidase-B (MAO-B), also inhibiting microglial production of neuroinflammatory mediators. This compound is specifically designed for research on neurodegenerative diseases .

  • hMAO-B-IN-32

    hMAO-B-IN-32 is a potent hMAO-B selective inhibitor with an IC50 of 45.52 μM.

  • Bazinaprine

    Bazinaprine is a selective, reversible monoamine oxidase inhibitor (MAOI) that is a candidate compound for the treatment of depression.